금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Bank of Canada: Strong GDP lowers cut risk – TD Securities
TD Securities’ Robert Both and Emma Lawrence note that stronger-than-expected Canadian Gross Domesti...
New Zealnd Dollar weakens after China PMI miss as the US Dollar rebounds
NZD/USD trades around 0.5860 on Friday, down 0.33% on the day, as investors react to another deterio...
Euro: Range seen around mid‑1.15s against US Dollar – Scotiabank
Scotiabank’s FX team notes EUR/USD is drifting toward 1.15 after a Fed‑driven rally, with euro area ...
Semiconductor, optical stocks surge as US fab investments mount
Mortgage rates hang out in the mid-6% range
NTIC expects gross margin to improve sequentially in Q4 as it pursues pricing and procurement initiatives
Risky leveraged ETFs are booming in 2026. Some worry they could be making the stock market more volatile.
Some say traders who gravitate toward these products see big swings in the underlying stocks as a feature, not a bug.
Redwood Trust jumps 7% after KBW rating upgrade
Update: US Equities Rise Intraday in Tech-Led Advance as Oil Prices Ease
(Updates with latest market prices and developments.) US benchmark equity indexes were higher int
Sector Update: Energy Stocks Fall Thursday Afternoon
Energy stocks were lower Thursday afternoon, with the NYSE Energy Sector Index falling 1.1% and the
AeroVironment downgraded as RBC questions ambitious growth targets
Best 3 AI ETF Picks for the Second Half of 2026
The artificial intelligence (AI) bull market remains alive and well. These ETFs offer three distinct ways to benefit from it.
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and regulatory risks keep pressure on the stock.
Simply Good Foods outlines $322M-$332M Q4 net sales outlook while planning high single-digit price increase in September
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.